In addition, melatonin can inhibit the RNA expression level of cyclin D1 in human breast cancer cells and the RNA and protein expression levels of cyclin D1, cyclin B1, CDK1, and CDK4 in osteosarcoma cells [114,115]. Here, CCND1 is linked to breast cancer.